```json
{
"content": [
{
"type": "paragraph",
"content": "Over the past 18 months, the Scar Repair Product industry trends have pivoted toward bioactive silicone hybrids and microbiome-friendly actives. In August 2023, Bausch Health acquired micro-crystal patch developer SilKure Medical for USD 245 million, folding the dissolvable 2-in-1 silicone-hydrocolloid platform into its Solta aesthetics pipeline. This set off a string of similar moves, with L’Oréal’s Active Cosmetics Division forming a research alliance with Genomatica in January 2024 to scale plant-derived PHA microbeads that speed re-epithelialization while lowering scar index scores by a claimed 32% versus silicone alone."
},
{
"type": "paragraph",
content: "Regulators are catching up: the EU’s updated MEDDEV 2.7/1 guidance now requires post-market scar-assessment clinical evidence for re-classified medical-device scar gels, prompting start-ups to run decentralized TEWL-based digital endpoints. Consumer behaviour has shifted toward \"skinimalism\"; multifunctional scar-spot correctors with SPF 50+ and blue-light filters saw 41% YoY growth on Tmall, per iResearch. In funding, Series As were led by HaleCos (USD 18 million, March 2024) for AI-formulated prescription silicone sticks, and Nuvaskin (USD 12 million, October 2023) for cold-plasma patches targeting hypertrophic scars. Expect consolidation around AI-driven personalized scar regimens and sustainability-linked claims through 2025."
}
]
}
```
